Young Women in Their Twenties Facing a Surge in Type 2 Diabetes

England’s health stats are sounding an alarm: more women in their early twenties are being diagnosed with type 2 diabetes than we’ve seen in recent memory. The uptick, researchers from Imperial College London point out, really took off after the Covid pandemic and mirrors a sharp climb in obesity among the same age group.

Type 2 diabetes isn’t just a numbers game – it can usher in heart attacks, strokes and a host of other complications. And when the disease shows up before the age of 30, it tends to be more aggressive, cutting lives short and piling on health problems, according to Diabetes UK.

The good news, however, is that early detection can make a huge difference. A diagnosis made promptly gives people a chance to stave off organ damage, and in some cases a healthy diet and weight loss can even push the condition into remission, sparing patients from long‑term medication.

Data from the English National Diabetes Audit, covering 2011‑2024, reveal a nuanced picture. While the overall number of new cases is slipping very slightly among older adults, the opposite is true for people under 40. The steepest climbs are seen in women aged 20‑29, where the prevalence of obesity at diagnosis has been rising faster than in any older cohort.

Obesity rates in England have indeed worsened post‑pandemic – almost one in three adults now carries excess weight, according to NHS figures. Between 2019 and 2025, new obesity cases jumped 16 % among 20‑29‑year‑olds and nearly 20 % for those in their thirties, while the over‑60s actually saw a modest decline.

Lead researcher Dr Shivani Misra explains, “We think the earlier onset of severe obesity is pulling the age of type 2 diabetes diagnosis down. It’s worrying because early‑onset disease carries poorer outcomes.” She adds that the trend isn’t confined to ethnic minority groups – it’s spreading across white populations too, making it a truly generational public‑health challenge.

Diabetes UK also flags the importance of follow‑up care for women who develop gestational diabetes during pregnancy, as they face a higher risk of type 2 diabetes later on. Some early studies even hint at a possible link between severe Covid infection and later diabetes, though the evidence remains inconclusive.

What can be done? Alongside traditional advice about healthier eating and staying active, newer obesity treatments – GLP‑1 injections and pills – may offer additional support. But the cornerstone remains early detection, lifestyle change and a health system ready to catch these cases before they spiral.